Cancer Research

Priming the immune system to attack cancer

An international team, co-led by the School of Dental Medicine’s George Hajishengallis, showed how immune “training” transforms certain immune cells to target tumors.

Katherine Unger Baillie

Avery Posey’s cancer research takes high risks for big rewards

The assistant professor of systems pharmacology and translational therapeutics, who studied with Carl June as a postdoctoral fellow, combines his two research passions—gene therapy and investigating ‘little known’ biology—in the pursuit of new knowledge.

From Penn Medicine News



In the News


CNN

There’s still no standard test to detect pancreatic cancer early. Scientists are working to change that

A 2020 study from the Perelman School of Medicine found that a blood test to screen for certain biomarkers associated with pancreatic cancer was 92% accurate in its ability to detect disease.

FULL STORY →



Associated Press

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

A clinical trial led by Stephen Bagley of the Perelman School of Medicine suggests that targeting two associated proteins with CAR T cell therapy could be a viable strategy for shrinking brain tumors.

FULL STORY →



Philadelphia Inquirer

Penn’s BRCA cancer vaccine trial aims to prevent the disease in healthy people

A trial led by Susan Domchek of the Perelman School of Medicine could use a preventive vaccine to protect people with a BRCA gene mutation from cancer.

FULL STORY →



Philadelphia Inquirer

UPenn scientists among those developing vaccines that arm the immune system to fight cancer

Penn Medicine researchers like Nobel laureate Drew Weissman are leading efforts to develop a vaccine that prevents cancer, with remarks from Susan Domchek of the Basser Center for BRCA and Robert H. Vonderheide of the Abramson Cancer Center.

FULL STORY →



Psychology Today

AI detects cancers and immunotherapy biomarker

Daiwei Zhang and Mingyao Li of the Perelman School of Medicine and colleagues have developed an AI tool called iStar that can automatically spot tumors and types of cancer that are difficult for clinicians to see or identify and can predict candidates for immunotherapy.

FULL STORY →



Philadelphia Inquirer

Penn started giving cancer patients free rides to appointments. It helped reduce no-shows and increase clinical trial enrollment

The Abramson Cancer Center is attempting to address one of the most common challenges cancer patients face: lack of transportation to critically important appointments. Robert Vonderheide and Carmen Guerra of the Perelman School of Medicine are quoted on the Ride Health initiative.

FULL STORY →